Tomoya Sasaki
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: October 10, 2022
A Case of Rheumatoid Arthritis Caused by Pembrolizumab Treatment for Non-Small Cell Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 17, 2021
Severe and progressive platythorax disproportionate to lung fibrosis: A rare variant of idiopathic pleuroparenchymal fibroelastosis.
Journal: Respiratory medicine case reports
Published: March 01, 2021
A 63-Year-Old Woman With an Acute Exacerbation of Interstitial Pneumonia.
Journal: Chest
Published: November 20, 2020
Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.
Journal: Journal of clinical medicine
Published: October 21, 2020
Risk factors for pneumocystis pneumonia onset in HIV-negative patients treated with high-dose systemic corticosteroids.
Journal: Infectious diseases (London, England)
Published: February 19, 2019
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
Journal: Investigational new drugs
Published: April 16, 2018
Aggressive Cystic and Cavitary Appearances in Lung Adenocarcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: January 05, 2017
Rare Pulmonary Manifestations of Metastatic Malignant Melanoma.
Journal: Internal medicine (Tokyo, Japan)
Published: June 16, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026